RESUMEN
Schistosomiasis affects approximately 40 million women of reproductive age and has been linked to elevated levels of circulating endotoxin in nonpregnant individuals. We have evaluated endotoxin levels in maternal, placental, and newborn blood collected from women residing in Leyte, Philippines. Endotoxin levels in both maternal and placental compartments in pregnant women with schistosomiasis were 1.3- and 2.4-fold higher, respectively, than in uninfected women. In addition, higher concentrations of endotoxin in placental blood were associated with premature birth, acute chorioamnionitis, and elevated proinflammatory cytokines. By promoting endotoxemia, schistosomiasis may exert additional, maladaptive influences on pregnancy outcomes.
Asunto(s)
Análisis Químico de la Sangre , Endotoxinas/sangre , Sangre Fetal/química , Complicaciones Parasitarias del Embarazo/patología , Esquistosomiasis Japónica/patología , Adulto , Citocinas/sangre , Femenino , Humanos , Recién Nacido , Filipinas , EmbarazoRESUMEN
Human peripheral blood BCRµ(+) B cells express high levels of CD23 and circulate preloaded with IgE. The Ag specificity of CD23-bound IgE presumably differs from the BCR and likely reflects the Ag-specific mix of free serum IgE. CD23-bound IgE is thought to enhance B cell Ag presentation to T cells raising the question of how a B cell might respond when presented with a broad mix of Ags and CD23-bound IgE specificities. We recently reported that an increase in CD23(+) B cells is associated with the development of resistance to schistosomiasis, highlighting the potential importance of CD23-bound IgE in mediating immunity. We sought to determine the relationship between BCR and CD23-bound IgE-mediated B cell activation in the context of schistosomiasis. We found that crude schistosome Ags downregulate basal B cell activation levels in individuals hyperexposed to infectious worms. Schistosome-specific IgE from resistant, occupationally exposed Kenyans recovered responses of B cells to schistosome Ag. Furthermore, cross-linking of CD23 overrode intracellular signals mediated via the BCR, illustrating its critical and dominating role in B cell activation. These results suggest that CD23-bound IgE augments and dominates recall responses through naive B cells.
Asunto(s)
Subgrupos de Linfocitos B/inmunología , Inmunidad Innata/inmunología , Inmunoglobulina E/metabolismo , Activación de Linfocitos/inmunología , Receptores de IgE/fisiología , Fase de Descanso del Ciclo Celular/inmunología , Esquistosomiasis mansoni/inmunología , Animales , Presentación de Antígeno/inmunología , Antígenos Helmínticos/inmunología , Antígenos Helmínticos/metabolismo , Subgrupos de Linfocitos B/citología , Subgrupos de Linfocitos B/metabolismo , Sitios de Unión de Anticuerpos , Línea Celular Tumoral , Humanos , Inmunidad Innata/genética , Inmunoglobulina E/fisiología , Memoria Inmunológica/genética , Líquido Intracelular/inmunología , Líquido Intracelular/parasitología , Ratones , Ratones de la Cepa 129 , Ratones Endogámicos NZB , Unión Proteica/inmunología , Receptores de IgE/biosíntesis , Receptores de IgE/metabolismo , Esquistosomiasis mansoni/metabolismo , Esquistosomiasis mansoni/prevención & controlRESUMEN
There is a need for developing vaccines that elicit mucosal immunity. Although oral or nasal vaccination methods would be ideal, current strategies have yielded mixed success. Toll-like receptor 2 (TLR2) ligands are effective adjuvants and are currently used in the Haemophilus influenzae type B vaccine. Induction of humoral immunity in the mucosa is critical for effective vaccination; thus, we sought to determine the effects of TLR2 ligands on human mucosal B cell differentiation. We demonstrate that TLR2 ligands induce CCR9 and CCR10 expression by circulating B cells and increased chemotaxis to cognate chemokines CCL25 and CCL28 suggesting that TLR2 induces B cell homing to the gastrointestinal tract. TLR2 stimulation of B cells also induced J chain and IgA production demonstrating the induction of mucosal-like antibody secreting cells. These observations suggest that vaccines containing TLR2-ligands as adjuvants could induce mucosal B cell immunity even when delivered in a non-mucosal manner.
Asunto(s)
Linfocitos B/metabolismo , Inmunidad Mucosa/inmunología , Inmunoglobulina A/biosíntesis , Receptores Mensajeros de Linfocitos/metabolismo , Receptor Toll-Like 2/metabolismo , Adolescente , Adulto , Anciano , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Quimiocinas CC/farmacología , Quimiotaxis/efectos de los fármacos , Quimiotaxis/inmunología , Enfermedad de Crohn/inmunología , Enfermedad de Crohn/patología , Profilaxis Dental , Femenino , Expresión Génica/efectos de los fármacos , Humanos , Íleon/inmunología , Íleon/metabolismo , Íleon/patología , Cadenas J de Inmunoglobulina/metabolismo , Inmunoglobulina M/metabolismo , Enfermedades Inflamatorias del Intestino/inmunología , Interleucina-10/farmacología , Mucosa Intestinal/inmunología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Lipopolisacáridos/sangre , Lipopolisacáridos/farmacología , Masculino , Persona de Mediana Edad , Tonsila Palatina/citología , Tonsila Palatina/inmunología , Porinas/inmunología , Porinas/farmacología , Receptores CCR/genética , Receptores CCR/metabolismo , Receptores CCR10/genética , Receptores CCR10/metabolismo , Adulto JovenRESUMEN
Chronic systemic inflammation links periodontal disease and diabetes to increased incidence of serious comorbidities. Activation of TLRs, particularly TLR2 and TLR4, promotes chronic systemic inflammation. Human B cells have been generally thought to lack these TLRs. However, recent work showed that an increased percentage of circulating B cells from inflammatory disease patients express TLR2 and TLR4, and that TLR engagement on B cells resulted in unexpected changes in gene expression. New data show that B cells from inflammatory disease patients secrete multiple cytokines in response to different classes of TLR ligands. Furthermore, the B cell response to combinations of TLR ligands is cytokine- and ligand-specific. Some cytokines (IL-1beta and IL-10) are predominantly regulated by TLR4, but others (IL-8 and TNF-alpha) are predominantly regulated by TLR2, due in part to TLR-dictated changes in transcription factor/promoter association. TLR2 and TLR9 also regulate B cell TLR4 expression, demonstrating that TLR cross-talk controls B cell responses at multiple levels. Parallel examination of B cells from periodontal disease and diabetes patients suggested that outcomes of TLR cross-talk are influenced by disease pathology. We conclude that disease-associated alteration of B cell TLR responses specifically regulates cytokine production and may influence chronic inflammation.
Asunto(s)
Linfocitos B/inmunología , Periodontitis Crónica/inmunología , Citocinas/biosíntesis , Receptor Cross-Talk/inmunología , Receptores Toll-Like/inmunología , Inmunoprecipitación de Cromatina , Periodontitis Crónica/metabolismo , Citometría de Flujo , Humanos , Receptores Toll-Like/metabolismoRESUMEN
The kappa intronic and the kappa 3' enhancers synergize to regulate recombination and transcription of the Ig kappa locus. Although these enhancers have overlapping functions, the kappa i enhancer appears to predominate during receptor editing, while the kappa 3' enhancer may be more important for initiating Ig kappa germline transcription to target locus recombination and, later in development, somatic hypermutation. Changes in chromatin structure appear to regulate both enhancers, and previous reports suggest that both enhancers are packaged into an accessible chromatin structure only in B lineage cells. Why these enhancers cannot activate the demethylated, accessible, protein-associated Ig kappa allele in pro-B cells is not known. Furthermore, how the enhancers function to reactivate the locus for receptor editing or to quantitatively promote hypermutation in B cells is vague. Quantitative analysis of Ig enhancer chromatin structure in murine pro-, pre-and splenic B cells demonstrated that the kappa i enhancer maintains a highly accessible chromatin structure under a variety of conditions. This stable chromatin structure mirrored the highly accessible structure characterizing the Ig mu intronic enhancer, despite the fact that Ig mu is activated prior to Ig kappa during B cell development. Surprisingly, parallel analysis of the kappa 3' enhancer demonstrated its accessible chromatin structure is markedly unstable, as characterized by sensitivity to changes in environmental conditions. These data unexpectedly suggest that kappa locus regulation is compartmentalized along the gene in B lineage cells. Furthermore, these findings raise the possibility that environmentally dependent regulation of kappa 3' enhancer structure underlies changes in kappa activation during B cell development.
Asunto(s)
Cromatina/química , Cromatina/genética , Elementos de Facilitación Genéticos , Regulación de la Expresión Génica/inmunología , Cadenas kappa de Inmunoglobulina/genética , Animales , Subgrupos de Linfocitos B/citología , Subgrupos de Linfocitos B/inmunología , Subgrupos de Linfocitos B/metabolismo , Diferenciación Celular/genética , Células Cultivadas , Cadenas mu de Inmunoglobulina/genética , Ratones , Ratones Endogámicos BALB C , Bazo/citología , Bazo/inmunología , Bazo/metabolismoRESUMEN
Striped skunks (Mephitis mephitis) from Cape Cod, Massachusetts, U.S.A. were necropsied (n=34; 1995-1997) or clinically evaluated (n=25, 2002-2003) to characterize a lameness and polyarthritis, reported by wildlife veterinarians and rehabilitators, and unsuccessfully treated with antibiotics. Overall, 22 affected skunks had one or multiple swollen joints, swollen paws, and subcutaneous abscesses. Purulent exudate was located in joint spaces, in periarticular connective tissue between muscle fascicles and tendons, and between and along flexor and extensor tendons of the paws. Histologic examination revealed suppurative arthritis, with necrosis and erosion of articular cartilage, and suppurative osteomyelitis. Special stains failed to reveal a causative microorganism within affected joints, and routine bacteriologic cultures failed to isolate a pathogen with any significant frequency or consistency. Polymerase chain reaction (PCR) experiments were performed using DNA extracted from archived, formalin-fixed joint samples of 11 affected skunks, and DNA from joints of 7 of 11 affected skunks yielded amplicons with sequences highly similar to sequences of Mycoplasma fermentans within the Mycoplasma bovis cluster, whereas DNA samples from joints of four unaffected skunks were negative by PCR. Skunks from Connecticut, U.S.A. (n=21; 1995-2003) were similarly examined and were found not to have suppurative polyarthritis, suggesting a unique geographic distribution of this condition. Concurrent pathologic conditions in adult skunks from both Cape Cod and Connecticut included verminous pneumonia, gastric nematodiasis, arthropod ectoparasitism, and canine distemper. Amyloidosis was present in skunks with and without suppurative polyarthritis, and the amyloid was immunohistochemically identified as AA-amyloid. This is the first report of suppurative polyarthritis in wild skunks with evidence of a mycoplasmal etiology.
Asunto(s)
Artritis Infecciosa/veterinaria , Artritis/veterinaria , Mephitidae/microbiología , Infecciones por Mycoplasma/veterinaria , Animales , Artritis/epidemiología , Artritis/microbiología , Artritis/patología , Artritis Infecciosa/epidemiología , Artritis Infecciosa/microbiología , Artritis Infecciosa/patología , Secuencia de Bases , ADN Bacteriano/análisis , Farmacorresistencia Bacteriana , Femenino , Inmunohistoquímica/veterinaria , Masculino , Massachusetts , Datos de Secuencia Molecular , Mycoplasma/efectos de los fármacos , Mycoplasma/aislamiento & purificación , Infecciones por Mycoplasma/epidemiología , Infecciones por Mycoplasma/microbiología , Infecciones por Mycoplasma/patología , Mycoplasma arthritidis/efectos de los fármacos , Mycoplasma arthritidis/aislamiento & purificación , ARN Bacteriano/análisis , Alineación de SecuenciaRESUMEN
A high level of serum IgE is generally associated with human resistance to schistosomes, though the protective mechanisms of IgE remain undefined. We recently reported that whereas some individuals who are occupationally hyperexposed to Schistosoma mansoni display resistance to reinfection, others remain highly susceptible, in some cases due to HIV-1 co-infection. As IgE functions, in part, through FcepsilonRI on mast cells, we characterized circulating CD117(+) FcepsilonRI(+) mast cell precursors in this population. Surprisingly, a higher percentage of CD117(+) cells correlated with a susceptible phenotype in HIV-1 seronegative participants with schistosomiasis. There was no association between percentages of peripheral CD117(+) cells and susceptibility to reinfection in persons with HIV-1. Serum levels of polyclonal IgE were inversely correlated with percentages of CD117(+) cells regardless of HIV-1 status. Thus, immature mast cells may affect IgE availability, or IgE may affect immature mast cells, altering the balance of host susceptibility and resistance to schistosomes.
Asunto(s)
Mastocitos/inmunología , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/inmunología , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Síndrome de Inmunodeficiencia Adquirida/inmunología , Animales , Recuento de Linfocito CD4 , Susceptibilidad a Enfermedades , Humanos , Recurrencia , Schistosoma mansoni , Esquistosomiasis mansoni/complicacionesRESUMEN
Immunocompetent male mice are more susceptible to experimental infection with Brugia spp. than are females. Because permissive male SCID mice (severe combined immunodeficient mice), which lack T and B cells, also possess higher worm burdens, the mechanism is not solely immune mediated. Recovery of fewer adult worms from the female SCID mouse suggests that females do not provide sufficient nutrients for larval growth. This study assessed the potential of the female SCID mouse to support the L3 to L4 molt of Brugia malayi. Unexpectedly, worms grown in females molted at earlier time points of recovery than those harvested from males. This suggests that the early stage of development of B. malayi is delayed in the male murine host. To determine whether the effect of host sex on molting may be similar in humans, worms were cultured in media supplemented with serum from male or female donors. Worms grown in serum obtained from female donors exhibited a significantly higher percentage of complete molts over those cultured with serum from males. Host-derived molecules required for the L3 to L4 molt may be more abundant in the female, perhaps allowing the worms to survive a vulnerable developmental stage in a less permissive environment.
Asunto(s)
Brugia Malayi/fisiología , Filariasis/parasitología , Muda/fisiología , Animales , Femenino , Filariasis/inmunología , Larva/fisiología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones SCID , Factores SexualesRESUMEN
Accumulation of macrophages and T cells within crown-like structures (CLS) in subcutaneous adipose tissue predicts disease severity in obesity-related insulin resistance (OIR). Although rodent data suggest the B cell is an important feature of these lesions, B cells have not been described within the human CLS. In order to identify B cells in the human subcutaneous CLS (sCLS) in obese subjects and determine whether the presence of B cells predict insulin resistance, we examined archived samples of subcutaneous and omental fat from 32 obese men and women and related findings to clinical parameters. Using immunohistochemistry, we identified B (CD19(+)) and T cells (CD3 (+)) within the sCLS and perivascular space. The presence and density of B cells (B cells per high-power field (pHPF), T cells pHPF, and B cell:T cell (B:T) ratio) were compared with measures of insulin resistance (homeostasis model assessment (HOMA)) and other variables. In 16 of 32 subjects (50%) CD19(+) B cells were localized within sCLS and were relatively more numerous than T cells. HOMA was not different between subjects with CD19(+) vs. CD19(-) sCLS (5.5 vs. 5.3, P = 0.88). After controlling for diabetes and glycemia (hemoglobin A(1c) (HbA(1c))), the B:T ratio correlated with current metformin treatment (r = 0.89, P = 0.001). These results indicate that in human OIR, B cells are an integral component of organized inflammation in subcutaneous fat, and defining their role will lead to a better understanding of OIR pathogenesis and potentially impact treatment.
Asunto(s)
Linfocitos B/patología , Glucemia/metabolismo , Hemoglobina Glucada/metabolismo , Obesidad/patología , Epiplón/patología , Grasa Subcutánea/patología , Adulto , Antígenos CD19/metabolismo , Linfocitos B/inmunología , Índice de Masa Corporal , Femenino , Humanos , Inmunohistoquímica , Resistencia a la Insulina , Masculino , Obesidad/inmunología , Epiplón/inmunología , Valor Predictivo de las PruebasRESUMEN
BACKGROUND: Bacteria have a central, although poorly understood, role in inflammatory bowel disease (IBD). Host-bacteria interactions primarily take place in the gastrointestinal tract, but cells may also encounter translocated bacteria in the bloodstream. IBD is associated with activated, circulating Toll-like receptor (TLR)2 and TLR4-expressing B cells suggesting that blood-borne microbial TLR ligands modulate B cell responses. METHODS: Serum levels of lipopolysaccharide (LPS)/endotoxin and high mobility group box 1 (HMGB1), an endogenous TLR ligand, were quantified in Crohn's disease (CD) and ulcerative colitis (UC). Responses of purified B cells to LPS and HMGB1 were correlated with levels of systemic TLR ligands and clinical parameters of disease. RESULTS: While IBD patients have increased levels of blood LPS, the net effect of endotoxemia has unexpected characteristics illustrating that LPS has both pro- and antiinflammatory roles through TLR4+ B cells. Experimental treatment of B cells demonstrates that the antiinflammatory effect of LPS is due to its hypo-acylation of lipid A suggesting an increased prevalence of systemic, hypo-acylated LPS in CD. In contrast, high levels of LPS are associated with disease activity in UC. HMGB1 activates B cells through TLR2 and CD36. Serum levels of HMGB1 correlate with spontaneous IL-8 production by B cells suggesting that blood-borne TLR2 ligands increase B-cell activation in vivo. CONCLUSIONS: Systemic TLR ligands modulate B cells towards either proinflammatory or antiinflammatory activity depending on the predominant ligand(s). Further, the circulating B cell may represent an important proxy for quantifying the LPS lipid A acylation burden in patients with IBD.
Asunto(s)
Linfocitos B/inmunología , Linfocitos B/metabolismo , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/inmunología , Receptores Toll-Like/metabolismo , Colitis Ulcerosa/metabolismo , Colitis Ulcerosa/patología , Enfermedad de Crohn/metabolismo , Enfermedad de Crohn/patología , Citocinas/metabolismo , Citometría de Flujo , Proteína HMGB1/metabolismo , Humanos , Ligandos , Lipopolisacáridos/farmacología , Activación de Linfocitos/efectos de los fármacos , Receptores Toll-Like/inmunologíaRESUMEN
Toll-like receptor 4 (TLR4) is an innate immune receptor that is constitutively and inducibly activated in monocytes. Although TLR4 is expressed at very low levels on human B cells from healthy individuals, recent reports showed that TLR4 expression and function is elevated in B cells from inflammatory disease patients. New data showed that TLR4 expression on B cells is increased upon stimulation through surface Igµ and CD40 in combination with IL-4. In contrast, monocyte stimulation through CD40 and IL-4 receptors decreased TLR4 surface expression. Analysis of molecular signatures of TLR4 activation in stimulated B cells suggested that TLR4 is regulated by different mechanisms in B cells compared to monocytes. PU.1 and interferon regulatory factor association with the TLR4 promoter are sufficient for TLR4 transcription, but are not sufficient for surface TLR4 expression on B cells. In contrast, the PU.1/IRF combination is sufficient for surface TLR4 expression on monocytes. These data identify mechanisms that can activate B cell TLR4 expression in inflammatory disease patients, and demonstrate that B cells have additional layers of TLR4 regulation absent in monocytes.
Asunto(s)
Linfocitos B/inmunología , Enfermedad de Crohn/inmunología , Regulación de la Expresión Génica/inmunología , Monocitos/inmunología , Receptor Toll-Like 4/biosíntesis , Separación Celular , Citometría de Flujo , Expresión Génica , Humanos , Activación de Linfocitos/genética , Activación de Linfocitos/inmunología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/inmunologíaRESUMEN
IgE plays a critical role in hypersensitivity reactions such as asthma and allergy as well as poorly defined roles in immunity to parasitic helminth infections. The quantity of antigen-specific IgE is thought to affect the intensity of the allergic reaction as well as the perceived level of resistance to parasitic worms. Because most somatic IgE is bound by its receptors, Fc epsilon RI and Fc epsilon RII, and increased expression of IgE receptors also change with cellular activation status, the serum concentration of IgE may not necessarily reflect levels of systemic IgE. Accurate measures of IgE would help to define the bona fide role of this molecule in immunity. Furthermore, improved indicators of systemic antigen-specific IgE could better predict the risk for severe allergic responses. In this report, we demonstrate a simple method for measuring cell-bound IgE in whole blood using basic flow cytometry. This method demonstrates that, in general, cell-bound IgE correlates well with serum levels of IgE. However, discordance in serum and cell-bound IgE levels in some individuals illustrates the inadequacy of using serum levels of IgE as a systemic indicator and validates the need to assay both cell-bound and free IgE
Asunto(s)
Citometría de Flujo/métodos , Inmunoglobulina E/sangre , Inmunoglobulina E/metabolismo , Receptores de IgE/metabolismo , Ensayo de Inmunoadsorción Enzimática , HumanosRESUMEN
Chronic systemic inflammation links periodontal disease (PD) to increased incidence of cardiovascular disease. Activation of TLRs, particularly TLR4, promotes chronic inflammation in PD by stimulating myeloid cells. B cells from healthy individuals are generally refractory to TLR4 agonists as a result of low surface TLR4 expression. Unexpectedly, a significantly increased percentage of gingival and peripheral blood B cells from patients with PD expressed surface TLR4. Surface expression correlated with an active TLR4 promoter that mimicked the TLR4 promoter in neutrophils. B cells from PD patients were surface myeloid differentiation protein 2-positive and also packaged the enhancer of a proinflammatory cytokine, IL-1 beta, into an active structure, demonstrating that these cells harbor key characteristics of proinflammatory cell types. Furthermore, B cells lacked activating signatures of a natural IL-1 beta inhibitor, IL-1 receptor antagonist. Surprisingly, despite multiple signatures of proinflammatory cells, freshly isolated B cells from PD patients had decreased expression of TLR pathway genes compared with B cells from healthy individuals. Decreases in inflammatory gene expression were even more dramatic in B cells stimulated with a TLR4 ligand from a periodontal pathogen, Porphyromonas gingivalis LPS 1690. In contrast, B cell TLR4 was not activated by the prototypic TLR4 ligand Escherichia coli LPS. These findings raise the unexpected possibility that TLR4 engagement modulates B cell activation in PD patients.
Asunto(s)
Linfocitos B/inmunología , Enfermedades Periodontales/inmunología , Receptor Toll-Like 4/inmunología , Proteínas Adaptadoras Transductoras de Señales/análisis , Estudios de Casos y Controles , Escherichia coli , Humanos , Mediadores de Inflamación/análisis , Interleucina-1beta/análisis , Lipopolisacáridos/farmacología , Activación de Linfocitos , Enfermedades Periodontales/patología , Regiones Promotoras Genéticas , Receptor Toll-Like 4/análisis , Receptor Toll-Like 4/genéticaRESUMEN
IBD is characterized by a chronic, dysregulated immune response to intestinal bacteria. Past work has focused on the role of T cells and myeloid cells in mediating chronic gastrointestinal and systemic inflammation. Here, we show that circulating and tissue B cells from CD patients demonstrate elevated basal levels of activation. CD patient B cells express surface TLR2, spontaneously secrete high levels of IL-8, and contain increased ex vivo levels of phosphorylated signaling proteins. CD clinical activity correlates directly with B cell expression of IL-8 and TLR2, suggesting a positive relationship between these B cell inflammatory mediators and disease pathogenesis. In contrast, B cells from UC patients express TLR2 but generally do not demonstrate spontaneous IL-8 secretion; however, significant IL-8 production is inducible via TLR2 stimulation. Furthermore, UC clinical activity correlates inversely with levels of circulating TLR2+ B cells, which is opposite to the association observed in CD. In conclusion, TLR2+ B cells are associated with clinical measures of disease activity and differentially associated with CD- and UC-specific patterns of inflammatory mediators, suggesting a formerly unappreciated role of B cells in the pathogenesis of IBD.
Asunto(s)
Linfocitos B/inmunología , Regulación de la Expresión Génica/fisiología , Enfermedades Inflamatorias del Intestino/inmunología , Interleucina-8/inmunología , Activación de Linfocitos , Receptor Toll-Like 2/inmunología , Adulto , Anciano , Linfocitos B/metabolismo , Linfocitos B/patología , Femenino , Humanos , Enfermedades Inflamatorias del Intestino/metabolismo , Enfermedades Inflamatorias del Intestino/patología , Interleucina-8/biosíntesis , Masculino , Persona de Mediana Edad , Linfocitos T/inmunología , Linfocitos T/metabolismo , Linfocitos T/patología , Receptor Toll-Like 2/biosíntesisRESUMEN
Efficacious adjuvants are important components of new vaccines. The neisserial outer membrane protein, PorB, is a TLR2 ligand with unique adjuvant activity. We demonstrate that PorB promotes Th2-skewed cellular immune response to the model Ag, OVA, in mice, including Ag-specific recall eosinophil recruitment to the peritoneum. PorB induces chemokine secretion by myeloid cells using both TLR2-dependent and -independent mechanisms, suggesting that anatomical distribution of TLR2(+) cells may not be a limiting factor for potential vaccine strategies. The results from this study suggest that PorB, and other TLR2 ligands, may be ideal for use against pathogens where eosinophilia may be protective, such as parasitic helminths.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Eosinofilia/inmunología , Helmintiasis/prevención & control , Porinas/farmacología , Receptor Toll-Like 2/agonistas , Vacunas/inmunología , Animales , Antígenos/inmunología , Quimiocinas/metabolismo , Eosinofilia/parasitología , Eosinófilos/efectos de los fármacos , Eosinófilos/inmunología , Helmintos/inmunología , Ligandos , Macrófagos Peritoneales/inmunología , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Ratones , Ratones Noqueados , Células Mieloides/efectos de los fármacos , Ovalbúmina/inmunología , Receptor Toll-Like 2/genética , Receptor Toll-Like 4/agonistasRESUMEN
Human B cells likely have a major role in the adjuvant activity of Toll-like receptor (TLR) 9 agonists by enhancing innate and adaptive immune responses. As several TLR2 ligands are promising vaccine adjuvant candidates, our aim was to characterize the effects of TLR2 stimulation on human B cell activation and differentiation using cells derived from healthy peripheral blood (PB), spleen, and diseased tonsils. We found a subset of partially differentiated TLR2+ PB and splenic B cells which responds to TLR2 agonists by mediating events involved in germinal center formation, such as upregulating CD77 and secreting chemokines. Furthermore, we show that TLR2-activated monocytes induce B cells to secrete significant quantities of IgM. Finally, activated TLR2+ B cells from tonsils are induced to secrete IgM directly by TLR2 ligands. Thus, TLR2 is likely involved in specific B cell-mediated functions and may be a viable vaccine adjuvant target in humans.
Asunto(s)
Linfocitos B/inmunología , Diferenciación Celular/inmunología , Tejido Linfoide/inmunología , Receptor Toll-Like 2/inmunología , Adulto , Antígenos CD19/sangre , Antígenos CD19/inmunología , Linfocitos B/citología , Diferenciación Celular/efectos de los fármacos , Femenino , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Activación de Linfocitos , Tejido Linfoide/citología , Masculino , Persona de Mediana Edad , Receptor Toll-Like 2/agonistas , Receptor Toll-Like 2/biosíntesis , Trihexosilceramidas/inmunologíaRESUMEN
Longitudinal investigations of an adult male population of Kenyan car washers who have heavy and quantifiable occupational exposure to Schistosoma mansoni cercariae revealed that some individuals develop resistance to reinfection while others remain highly susceptible. We sought to characterize immune correlates associated with host protection in this population. Previous studies have demonstrated an association of peripheral eosinophilia with resistance to reinfection with schistosomes. Thus, we investigated the relationship between the percentage of circulating eosinophils and the effect of human immunodeficiency virus type 1 (HIV-1) coinfection on the susceptibility of the car washers to reinfection with schistosomes. Elevated percentages of circulating eosinophils were associated with resistance to reinfection by S. mansoni in HIV-1-seronegative persons. In the HIV-1-seropositive cohort, low CD4+-T-cell counts were associated with a less intense eosinophilia. Moreover, eosinophils from the car washers expressed high levels of FcepsilonRI beta chain, a molecule important in immunoglobulin E (IgE)-mediated immunity. Levels of FcepsilonRI beta chain expression correlated with serum levels of total and antigen-specific IgE for HIV-1-negative car washers, but this was not the case for individuals coinfected with HIV-1. Overall, these data further implicate eosinophils as having a potential role in development of protective immunity against schistosomes and suggest that changes associated with HIV-1 coinfection increase susceptibility to reinfection.